Effect of antimalarials on clinical outcomes in lupus nephritis.

Óscar R Peña-VizcarraMaría Fernanda Zavala-MirandaBernardo Juárez-CuevasSofía E Márquez-MacedoAdriana Hernández-AndradeAlberto Nordmann-GomesAbril A Pérez-AriasLuis E Morales-BuenrostroJuan Manuel Mejía-Vilet

Published in: Rheumatology (Oxford, England) (2023)

The use of antimalarial drugs is associated with increased response to therapy, lower incidence of kidney flares, and lower progression to kidney failure in LN patients. Conversely, this population is at high risk of toxic maculopathy, and yearly ophthalmologic examination is recommended.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
risk factors
stem cells
drug induced